Dear AuntMinnieEurope Member,
"There are not enough evangelists out there," said Dr. Val Lewington, from King's College London, at last week's Brussels summit on molecular imaging.
Molecular imaging is at the forefront of innovation and technology and opens the way to personalized medicine, but the message is still not getting through to key decision-makers, she thinks. Our reporter, Leo Cendrowicz, was in the audience, and you can read his article in our Molecular Imaging Digital Community, or by clicking here. Also, don't miss his second article from the Brussels summit about the promise of targeted radionuclide therapy.
The word "pioneer" tends to be overused, or even abused. But in the case of Guido Holzknecht, the term is undoubtedly justified, given his major contribution to chest radiology. Our history columnist Dr. Adrian Thomas urges everyone to follow his example and show a similar dedication in their daily practice. Go to our Digital X-Ray Community, or click here.
If he were alive today, Holzknecht would probably be closely involved in the development of chest tomosynthesis, which is making sustained clinical progress. Important new research in this field has just been published by Swedish researchers. Get the story here.
What do radiologists really want from PACS? That was the main question asked in a Dutch survey conducted in September 2013. The findings contain a few surprises, and are worth a close look. You can do so by visiting the Healthcare Informatics Digital Community, or by clicking here.
Pulmonary MRI can be used to evaluate acute pulmonary embolism, offering an alternative for patients who can't undergo CT pulmonary angiography or are allergic to iodinated contrast agents, according to Turkish research presented at last week's American Roentgen Ray Society (ARRS) annual meeting. Click here to read more.
